Amr Abbas, MD
Interventional Cardiology · Berkley, MINPI 1346290046
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (40.6%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. Edwards Lifesciences accounts for 90.8% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2024 at $120,668 and has fallen 59.9% since, to $48,366 in 2025. Among interventional cardiology clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 476 payments — averaging $873.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Edwards Lifesciences$378K
- Lantheus Medical Imaging, Inc.$31K
- Medtronic$3K
- Abbott$2K
- Boston Scientific$824
- Shockwave Medical, Inc$176
- plus $558 from 7 others
Across 22 payments — averaging $6435.23 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Edwards Lifesciences$122K
- Abbott$19K
- Abiomed$135
What the payments were for
- Consulting fees$102,94425%
- Speaking & faculty fees$168,72741%
- Travel & lodging$128,17531%
- Food & beverage$15,6924%
- Education$970%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Edwards Lifesciences | 345 | $377,527 |
| Lantheus Medical Imaging, Inc. | 24 | $31,337 |
| Medtronic(2 entities) | 45 | $3,453 |
| Abbott | 20 | $1,761 |
| Boston Scientific | 22 | $824 |
| Shockwave Medical, Inc | 1 | $176 |
| Sunovion Pharmaceuticals Inc. | 11 | $151 |
| Biosense Webster, Inc. | 1 | $138 |
| Truvic Medical, Inc. | 1 | $114 |
| Novo Nordisk | 3 | $97 |
| Abiomed | 1 | $27 |
| Cardiva Medical, Inc. | 1 | $17 |
| Sanofi-aventis U.S. LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Edwards SAPIEN 3 Transcatheter Heart Valve$264,480
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$36,847
- Definity$31,000
- SAPIEN 3 Ultra RESILIA$13,743
- PASCAL$12,767
- CoreValve Evolut$1,099
- COREVALVE EVOLUT R$999
- AMPLATZER Occluders$638
- SYMPLICITY G3$437
- AMPLATZER$276
- MitraClip$254
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$176
- ESPRIT$170
- SYNERGY$156
- AVVIGO Guidance System$149
- NUVISION ICE CATHETER$138
- EVOQUE$138
How this compares
$415,635 in reported general payments places this provider in the 95th percentile of 187 interventional cardiology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 269 | $341,693 |
| Repatha SureclickEvolocumab | 76 | $76,030 |
| XareltoRivaroxaban | 44 | $53,065 |
| EntrestoSacubitril/Valsartan | 28 | $38,344 |
| JardianceEmpagliflozin | 18 | $19,272 |
| Praluent PenAlirocumab | 19 | $10,935 |
| BrilintaTicagrelor | 11 | $10,912 |
| Repatha SyringeEvolocumab | 11 | $7,803 |
| Ranolazine ErRanolazine | 25 | $4,716 |
| Ezetimibe | 135 | $4,219 |
| Rosuvastatin Calcium | 179 | $3,708 |
| Metoprolol Succinate | 167 | $3,675 |
| Atorvastatin Calcium | 320 | $3,650 |
| Amlodipine Besylate | 375 | $2,422 |
| ClopidogrelClopidogrel Bisulfate | 174 | $2,313 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Berkley
- Amir KakiDetroit$1.8M
- Tamam MohamadDetroit$960K
- Paul GrossmanAnn Arbor$630K
- Jason RicciPetoskey$594K
- Tim FischellKalamazoo$468K
- Mir BasirDetroit$442K
- Safwan KassasSaginaw$340K
- Vishal GuptaKalamazoo$293K
- Khaldoon AlaswadDetroit$276K
- Marcel ZughaibSouthfield$257K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.